72 research outputs found
Recent developments and strategies in pediatric pharmacology research in the USA
Research in pediatric pharmacology has undergone major changes in the last ten years, with an expansion in both publicly and privately funded activities. A number of pharmacokinetics studies and multi-site controlled efficacy trials have been conducted, so that treatment of children and adolescents can now be better informed and evidence-based. Regulatory financial incentives to industry in return for studies on drugs still covered by patent exclusivity have resulted in a substantial increase in pediatric research funded by pharmaceutical companies. In parallel, public funding has supported research on off-patent medications and other clinical important aspects of treatment, such as comparisons between active treatments, including non-pharmacological interventions. With greater interest by industry in pediatric research, the role of government funding agencies has been redefined to avoid duplication and ensure better integration of efforts and utilization of resources. The present review discusses some of the recent developments in pediatric pharmacology with focus on psychiatric medications
Oral chloral hydrate provides effective and safe sedation in paediatric magnetic resonance imaging
Use of naloxone during neonatal resuscitation in Australia: Compliance with published guidelines
Paediatric sedation guidelines: where we came from, where we are now, and current drug controversies
Unlicensed and off-label drug use in an Irish neonatal intensive care unit: a prospective cohort study
A survey of obstetrical anaesthesia practice, teaching and research in canadian university departments of anaesthesia
- …